ID
23275
Beschrijving
Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00147745
Link
https://clinicaltrials.gov/show/NCT00147745
Trefwoorden
Versies (1)
- 01-07-17 01-07-17 -
Geüploaded op
1 juli 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Type 2 Diabetes NCT00147745
Eligibility Type 2 Diabetes NCT00147745
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Lipid-lowering therapy Dosage Change | Antihypertensive Agents Dosage Change
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0585943
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0392747
- UMLS CUI [2,1]
- C0003364
- UMLS CUI [2,2]
- C0178602
- UMLS CUI [2,3]
- C0392747
Beschrijving
colesevelam | Hyperlipidemia
Datatype
boolean
Alias
- UMLS CUI [1]
- C0541155
- UMLS CUI [2]
- C0020473
Beschrijving
Serum Triglyceride Measurement
Datatype
boolean
Alias
- UMLS CUI [1]
- C0542495
Beschrijving
Low density lipoprotein cholesterol measurement
Datatype
boolean
Alias
- UMLS CUI [1]
- C0202117
Similar models
Eligibility Type 2 Diabetes NCT00147745
- StudyEvent: Eligibility
C0038766 (UMLS CUI [2])
C0013227 (UMLS CUI [3,1])
C0205394 (UMLS CUI [3,2])
C1272691 (UMLS CUI [3,3])
C0028754 (UMLS CUI [2])
C1305855 (UMLS CUI [3])
C0178602 (UMLS CUI [1,2])
C0392747 (UMLS CUI [1,3])
C0003364 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
C0020473 (UMLS CUI [2])